CPRX

Catalyst Pharmaceuticals, Inc.

Contracts

Total Value

Stock Metrics

0.3%

Short % Float

1.0d to cover · Low squeeze

90.0%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

15.3% of float

115.6M sh

Public Float

35/100

Dilution Score

Medium

24+ mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

35/100

MEDIUM

Inst: 90.0% · Top: Blackrock Inc.

Biotech Analytics

Rare Disease

6.99

Biotech Grade: F

Insider Buying0

Publications100

Dilution Risk35

Clinical Trials0

Short Interest10